Knowledge (XXG)

Camille Guérin

Source 📝

31: 245:, could immunize the animals without causing the disease. Henceforth, he and Calmette developed ways of attenuate the pathogenic activity of Mycobacterium, using successive transferrals of culture. In 1908, after successfully obtaining an immunologically active preparation that could be used to produce a vaccine, he published with Calmette the results of what was named the BCG. 248:
In 1919 he was promoted again, this time to Head of Services. Finally, in 1921, after 230 passages of the BCG culture, they obtained an effective vaccine that could be used in humans. In 1928 he moved to Paris to become the director of the Tuberculosis Service at the Pasteur Institute.
256:). In 1948 Guérin was chairman of the First International Congress on BCG. He was also President of the Veterinary Academy of France (1949), and President of the Academy of Medicine (1951). In 1955, the French Academy of Sciences awarded him the Scientific Grand Prix. 235:
At Lille, he was promoted to Head of Laboratory in 1900. Thereafter, from 1905 to 1915, and from 1918 to 1928 he devoted himself to the research on a vaccine against tuberculosis, in close association with Calmette, until Calmette's death in 1933.
185:
to a family of modest means. His father died of tuberculosis in 1882 (as well as his wife, in 1918). He studied veterinary medicine at the Ecole Nationale Vétérinaire d'Alfort from 1892 to 1896, working, while a student, as an assistant to
526: 360: 531: 480: 511: 474: 521: 506: 276: 274:
Hawgood, Barbara J (2007). "Albert Calmette (1863–1933) and Camille Guérin (1872–1961): the C and G of BCG vaccine".
158: 89: 197: 117: 516: 383:
Gyermekgyógyászat: Az Orvosegészségügyi Szakszervezet Gyermekorvos Szakcsoportjának folyóirata = Pediatriia
501: 496: 260: 232:
as intermediate hosts and developed a method to quantify the remaining virulence of these vaccines.
241: 301: 455: 434: 390: 369: 346: 293: 424: 416: 336: 328: 319: 285: 252:
In 1939 he became vice-president of the "Comité National de Défense contre la Tuberculose" (
213: 154: 137: 36: 358:""no truce for tuberculosis". 4. the birth of BCG. Albert Calmette and Camille Guerin". 429: 402: 146: 341: 314: 490: 190: 305: 170: 166: 142: 107: 30: 216:(1863–1933). He started as a technician in charge of preparing Calmette's serum ( 150: 289: 420: 228:. He considerably improved the production techniques of the latter by using 217: 209: 187: 459: 438: 394: 373: 297: 350: 332: 407: 225: 182: 58: 162: 229: 205: 221: 201: 77: 239:
He discovered in 1905 that the bovine tuberculosis bacillum, the
16:
French veterinarian and scientist, codeveloped of BCG vaccine
527:
Academic staff of the University of Lille Nord de France
381:
Lugosi, L (1963). "Albert Calmette and Camille Guerin".
113: 103: 85: 66: 44: 21: 208:) and started to work with its director, French 141:; 22 December 1872 – 9 June 1961) was a French 254:National Defense Committee against Tuberculosis 8: 29: 18: 428: 340: 483:. Pasteur Institute, Paris (In French). 448:Annales de l'Institut Pasteur de Lille 136: 7: 315:"BCG: who were Calmette and Guérin?" 361:Indian Journal of Medical Sciences 212:, bacteriologist and immunologist 14: 224:bites) and the vaccine against 35:Camille Guérin, a portrait of 1: 446:Gernez-Rieux, C (1961). "". 277:Journal of Medical Biography 181:Camille Guérin was born in 548: 481:Camille Guérin (1872–1961) 475:Jean Marie Camille Guérin 198:Institut Pasteur de Lille 130:Jean-Marie Camille Guérin 123: 118:Institut Pasteur de Lille 96: 28: 290:10.1258/j.jmb.2007.06-15 259:He died aged 88, in the 159:Bacillus Calmette-Guérin 90:Bacillus Calmette-Guérin 421:10.1136/bmj.1.5242.1834 196:In 1897, he joined the 532:French bacteriologists 512:Scientists from Lille 333:10.1136/thx.38.11.806 522:French veterinarians 507:People from Poitiers 415:(5242): 1834. 1961. 389:. Hungary: 321–322. 39:is seen to the right 242:Mycobacterium bovis 153:who, together with 477:. WhoNamedIt site. 313:Sakula, A (1983). 368:: 418–419. 1964. 127: 126: 98:Scientific career 539: 463: 442: 432: 403:"Camille GUERIN" 398: 377: 354: 344: 309: 157:, developed the 140: 135: 73: 55:22 December 1872 54: 52: 33: 19: 547: 546: 542: 541: 540: 538: 537: 536: 487: 486: 471: 466: 445: 401: 380: 357: 327:(11): 806–812. 312: 273: 269: 261:Hôpital Pasteur 214:Albert Calmette 179: 155:Albert Calmette 138:[ɡeʁɛ̃] 133: 81: 75: 71: 62: 56: 50: 48: 40: 37:Albert Calmette 24: 17: 12: 11: 5: 545: 543: 535: 534: 529: 524: 519: 517:Vaccinologists 514: 509: 504: 499: 489: 488: 485: 484: 478: 470: 469:External links 467: 465: 464: 443: 399: 378: 355: 310: 284:(3): 139–146. 270: 268: 265: 178: 175: 147:bacteriologist 125: 124: 121: 120: 115: 111: 110: 105: 101: 100: 94: 93: 87: 86:Known for 83: 82: 76: 74:(aged 88) 68: 64: 63: 57: 46: 42: 41: 34: 26: 25: 23:Camille Guérin 22: 15: 13: 10: 9: 6: 4: 3: 2: 544: 533: 530: 528: 525: 523: 520: 518: 515: 513: 510: 508: 505: 503: 500: 498: 495: 494: 492: 482: 479: 476: 473: 472: 468: 461: 457: 453: 449: 444: 440: 436: 431: 426: 422: 418: 414: 410: 409: 404: 400: 396: 392: 388: 384: 379: 375: 371: 367: 363: 362: 356: 352: 348: 343: 338: 334: 330: 326: 322: 321: 316: 311: 307: 303: 299: 295: 291: 287: 283: 279: 278: 272: 271: 266: 264: 262: 257: 255: 250: 246: 244: 243: 237: 233: 231: 227: 223: 219: 215: 211: 207: 203: 199: 194: 193:(1850–1903). 192: 191:Edmond Nocard 189: 184: 176: 174: 172: 168: 164: 160: 156: 152: 148: 144: 139: 131: 122: 119: 116: 112: 109: 106: 102: 99: 95: 91: 88: 84: 79: 69: 65: 60: 47: 43: 38: 32: 27: 20: 451: 447: 412: 406: 386: 382: 365: 359: 324: 318: 281: 275: 258: 253: 251: 247: 240: 238: 234: 195: 180: 171:tuberculosis 167:immunization 151:immunologist 143:veterinarian 129: 128: 114:Institutions 108:Bacteriology 97: 72:(1961-06-09) 502:1961 deaths 497:1872 births 188:pathologist 70:9 June 1961 491:Categories 267:References 263:in Paris. 51:1872-12-22 218:antivenom 210:physician 177:Biography 161:(BCG), a 460:13960535 439:14447432 408:Br Med J 395:14097501 374:14179613 306:41880560 298:17641786 226:smallpox 220:against 183:Poitiers 169:against 80:, France 61:, France 59:Poitiers 454:: 1–4. 430:1954438 351:6359561 230:rabbits 163:vaccine 134:French: 458:  437:  427:  393:  372:  349:  342:459668 339:  320:Thorax 304:  296:  206:France 104:Fields 302:S2CID 222:snake 202:Lille 92:(BCG) 78:Paris 456:PMID 435:PMID 391:PMID 370:PMID 347:PMID 294:PMID 165:for 149:and 67:Died 45:Born 425:PMC 417:doi 337:PMC 329:doi 286:doi 493:: 452:12 450:. 433:. 423:. 411:. 405:. 387:14 385:. 366:18 364:. 345:. 335:. 325:38 323:. 317:. 300:. 292:. 282:15 280:. 204:, 173:. 145:, 462:. 441:. 419:: 413:1 397:. 376:. 353:. 331:: 308:. 288:: 200:( 132:( 53:) 49:(

Index


Albert Calmette
Poitiers
Paris
Bacillus Calmette-Guérin
Bacteriology
Institut Pasteur de Lille
[ɡeʁɛ̃]
veterinarian
bacteriologist
immunologist
Albert Calmette
Bacillus Calmette-Guérin
vaccine
immunization
tuberculosis
Poitiers
pathologist
Edmond Nocard
Institut Pasteur de Lille
Lille
France
physician
Albert Calmette
antivenom
snake
smallpox
rabbits
Mycobacterium bovis
Hôpital Pasteur

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.